Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 17, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 17, Status: Authorised
AAdmin
٢٧ أكتوبر ٢٠٢٦
1 دقيقة قراءة
